Akari Therapeutics announces the appointment of Rob Bazemore to the Akari Board of Directors effective September 17, 2024. From 2015 to 2021, Mr. Bazemore served as the President, Chief Executive Officer and member of the Board of Directors of Epizyme.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX: